Welcome to our dedicated page for Coca-Cola Europacific Partners Plc news (Ticker: CCEP), a resource for investors and traders seeking the latest updates and insights on Coca-Cola Europacific Partners Plc stock.
Coca-Cola Europacific Partners plc (CCEP) is a major soft drink manufacturing and consumer goods company operating across 31 countries in Europe and the Australia, Pacific & Southeast Asia (APS) region. News about CCEP frequently centres on trading updates, interim and half-year results, and full-year preliminary figures, where the company reports on volume in unit cases, revenue, revenue per unit case and operating profit across its European and APS segments.
Investors following CCEP news can expect regular updates on quarterly performance, including Q1, Q3 and half-year trading statements, as well as guidance for the current financial year. These releases often discuss trends in the Home and Away from Home channels, category performance for Coca-Cola trademark beverages, flavours and mixers, water, sports, RTD tea and coffee, and other beverages including energy drinks, and the impact of factors such as weather, consumer sentiment and taxation in different markets.
Company announcements also cover capital allocation decisions, such as interim dividend declarations and the execution of a share buyback programme of up to €1 billion of ordinary shares. Additional news items include changes to CCEP’s UK listing category, confirmation of its inclusion in the FTSE 100 and FTSE All Share indices, and its ongoing membership of the NASDAQ 100. Governance-related updates, such as Board succession and director appointments, are reported through regulatory announcements and associated Form 6-K filings.
For readers tracking developments in the non-alcoholic ready to drink (NARTD) sector, CCEP’s news flow provides insight into how a large Coca-Cola bottling partner manages pricing, promotions, pack mix and category innovation across multiple geographies. Bookmark this page to access a consolidated feed of market announcements, earnings-related releases and other official communications about CCEP (CCEP).
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Coca-Cola Europacific Partners (CCEP) recently released its Q1 2023 Trading Update, showcasing a strong start to the year. The company reported:
- Revenue of €4,154 million, reflecting a growth of 12.0% and 14.0% on a fx-neutral basis.
- Comparable volume growth at 4.0%, driven by a robust performance in both the home and away-from-home channels.
- Interim dividend of €0.67 per share, with an annual payout ratio targeted at 50%.
CCEP reaffirms its FY23 guidance, expecting revenue growth of 6-8% and operating profit growth of 6-7%, amid ongoing uncertainties in market conditions.
Coca-Cola Europacific Partners plc (CCEP) has released the Notice of Meeting for its 2023 Annual General Meeting (AGM), scheduled for 4.30pm BST on 24 May 2023 in London. The company reaffirms its comparable operating profit guidance for the year ending 31 December 2023, consistent with its full year results disclosed on 16 February 2023. Shareholders can access the 2022 Integrated Report and Form 20-F, published on 17 March 2023, at the provided links. The Notice of AGM and Form of Proxy will be available on the National Storage Mechanism, ensuring compliance with Listing Rule 14.3.6R. Additionally, CCEP's Q1 2023 trading update is set to be announced on 25 April 2023.
Coca-Cola Europacific Partners plc (CCEP) has filed its 2022 Integrated Report and Form 20-F with the Securities and Exchange Commission on March 17, 2023. This report includes CCEP's audited financial results for the year ending December 31, 2022. Unaudited fourth-quarter results were released on February 16, 2023. The integrated report can be accessed on CCEP's website and the SEC site. Printed copies will be sent to shareholders who requested them around April 12, 2023.
Coca-Cola Europacific Partners (CCEP) reported strong preliminary unaudited results for FY 2022, highlighting a total revenue of €17.32 billion, a 26% increase from 2021. Volume grew by 17.5% to 3,300 million unit cases. Operating profit reached €2.09 billion, marking a 37.5% rise. The diluted EPS was €3.29, reflecting a 53% increase. CCEP maintained a dividend payout ratio of approximately 50%, distributing a record dividend of €1.68 per share. CEO Damian Gammell emphasized the company's commitment to growth, sustainability, and strategic investments, including a buyout in the Indonesian market, showcasing resilience in a dynamic market landscape.